Clinical trial
Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected…
NCT00043966 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00043966 |
|---|---|
| Title | Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects |
| Official title | A Randomized, Open-Label Study of 800 Mg Lopinavir/200 Mg Ritonavir QD in Combination With Tenofovir and Emtricitabine Vs. 400 Mg Lopinavir /100 Mg Ritonavir BID in Combination With Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Lopinavir/ritonavir, Tenofovir DF, Emtricitabine |
| Enrollment | 200 |
| Start date | Jul 1, 2002 |
| First posted | Aug 19, 2002 |
| Last update posted | Jul 27, 2006 |
| Countries | Australia, France, Germany, Singapore, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: